Alexis Borisy is Partner at Third Rock Ventures, where he focuses on the formation, development and strategy of new companies. He’s co-founded, served as interim CEO and is currently Chairman of the Board of both Foundation Medicine and Warp Drive Bio, and co-founded and served as interim CEO of Blueprint Medicines. He is also a Board Member of Editas Medicine.
Previously, Alexis founded and was CEO of CombinatoRx, and brought the company public on the NASDAQ. He has raised more than $1b in financing and business development deals, and has authored numerous scientific papers and patents. During his time at Harvard, he was a Howard Hughes Predoctoral Fellow, named the Massachusetts Institute of Technology’s Technology Review Innovator of the Year and was chosen as the New England Entrepreneur of the Year in Life Sciences.
Please login to leave a comment